There was an unexpected surge in the diagnosis of Type 1 diabetes among children and teenagers worldwide amidst the global impact of the COVID-19 pandemic, according to a new study. The systematic review, published by the Journal of the American Medical Association (JAMA), analyzed 42 studies on diabetes incidence, including 17 studies involving nearly 38,000…
Rise in Type 1 Diabetes Among Young People Linked to COVID-19: How to Prevent Autoimmune Diseases
Vitamin K Protects Against Diabetes, New Study Finds
June 30, 2023
admin
BrightdiabetesFoodHealth & SafetyLifestyleScienceScience Newstype 1 diabetestype 2 diabetesVitamin K
0 Comment
A recently published Canadian study has discovered the cellular process that allows vitamin K to protect against diabetes. The discovery opens up new ways to treat and prevent this growing epidemic that affects 415 million people worldwide. Vitamin K helps with gamma-carboxylation, one of the countless biochemical processes that our cells carry out, turning one substance…
‘Strong Association’ Between Obesity and Autoimmune Disease: Report
April 10, 2023
admin
autoimmune diseasesHealth & SafetyLifestyleMultiple SclerosisobesityObesity CrisisSocial Issuestype 1 diabetesUS
0 Comment
There is “compelling epidemiological evidence” revealing a “strong association” between being obese or overweight and the risk of developing autoimmune diseases like Type 1 diabetes and multiple sclerosis. “From an immunological standpoint, the cellular and molecular mechanisms linked to this association include the overstimulation of T lymphocytes by nutrient- and energy-sensing pathways,” according to a…
All You Need to Know About Diabetes: Early Signs, Causes, Mindsets, and Natural Remedies
Diabetes is a chronic, metabolic disease characterized by abnormally high blood sugar levels. High blood sugar levels can do serious damage to the eyes, kidneys, and other organs. This is why it is vital to seek treatment if you suspect you may have diabetes. It was estimated in 2019 that 37.3 million Americans—11.3 percent of…
Major Drugmaker to Drastically Reduce Insulin Prices in United States
March 15, 2023
admin
affordable insulinBusiness & MarketsCompaniesHealth & SafetyinsulinLifestyleSocial Issuestype 1 diabetestype 2 diabetesUSUS News
0 Comment
Drugmaker Novo Nordisk has announced that it will significantly reduce insulin prices in the United States beginning next year—a relief for Americans struggling with high prices. Denmark-based Novo Nordisk will lower U.S. prices of several pre-filled insulin pens and vials by up to 75 percent for people living with Type 1 and Type 2 diabetes,…
Thousands of Australians Face Skyrocketing Costs as Labor Price Cut Force Lifesaving Drug From PBS
The federal government is under pressure from the Coalition after removing a key lifesaving drug from the pharmaceutical benefits scheme (PBS), sending its cost soaring for thousands of Australians. Fifteen thousand Australians, many whom are children, who rely on Novo Nordisk’s fast-acting insulin drug Fiasp to manage their Type 1 diabetes will now face skyrocketing…
Type 2 Diabetes Among American Youth Predicted to Soar 673 Percent in Coming Decades: Expert Forecast
January 2, 2023
admin
diabetes among young americansdiabetes risksHealth & SafetyLifestyleSocial Issuestype 1 diabetestype 2 diabetesUSUS News
0 Comment
A new modeling study has found that the number of young Americans who are likely to develop type 2 diabetes in the country could rise almost sevenfold over the next 40 years—an estimate that has shocked some experts. The study, “Projections of Type 1 and Type 2 Diabetes Burden in the U.S. Population Aged <20…
New Study: Intermittent Fasting May Alleviate Type 2 Diabetes
Diabetes has become the third most life-threatening disease after cardiovascular disease and malignant tumors. According to the International Diabetes Federation, about 500 million people worldwide have diabetes mellitus and the number is increasing by 25,000 yearly, and those affected are found to be younger. A recent study shows that intermittent fasting can alleviate type 2…
FDA Approves First Drug That ‘Can Delay’ Stage 3 Type 1 Diabetes
The U.S. Food and Drug Administration (FDA) announced Thursday it approved a new drug that “can delay” the onset of stage 3 type 1 diabetes, which is the symptomatic stage of type 1 diabetes. The drug, teplizumab-mzwv, is to be used to delay the onset of stage 3 type 1 diabetes in adults and pediatric…
World’s-First Gene Therapy Developed for Type 1 Diabetes
October 31, 2022
admin
Australiaautoimmune diseasegene therapyHealth & SafetyinsulinLifestyleScienceScience Newstype 1 diabetesWorld
0 Comment
The Australian government has given a funding boost to an Australian biomedical research organisation, the Garvan Institute of Medical Research, to conduct clinical trials for the world’s first gene therapy for type 1 diabetes. The therapy was also developed thanks to the government’s ten-year $600 million (US$385 million) research accelerator program, targeted at addressing chronic and complex diseases….
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta